These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15471374)

  • 1. Frontal parenchymal atrophy measures in multiple sclerosis.
    Locatelli L; Zivadinov R; Grop A; Zorzon M
    Mult Scler; 2004 Oct; 10(5):562-8. PubMed ID: 15471374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normalized regional brain atrophy measurements in multiple sclerosis.
    Zivadinov R; Locatelli L; Stival B; Bratina A; Grop A; Nasuelli D; Brnabic-Razmilic O; Zorzon M
    Neuroradiology; 2003 Nov; 45(11):793-8. PubMed ID: 14551760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of sexual dysfunction and brain magnetic resonance imaging in multiple sclerosis.
    Zorzon M; Zivadinov R; Locatelli L; Stival B; Nasuelli D; Bratina A; Bosco A; Tommasi MA; Pozzi Mucelli RS; Ukmar M; Cazzato G
    Mult Scler; 2003 Feb; 9(1):108-10. PubMed ID: 12617277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.
    Zivadinov R; Sepcic J; Nasuelli D; De Masi R; Bragadin LM; Tommasi MA; Zambito-Marsala S; Moretti R; Bratina A; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):773-80. PubMed ID: 11385012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A semiautomated measure of whole-brain atrophy in multiple sclerosis.
    Bermel RA; Sharma J; Tjoa CW; Puli SR; Bakshi R
    J Neurol Sci; 2003 Apr; 208(1-2):57-65. PubMed ID: 12639726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproducibility and accuracy of quantitative magnetic resonance imaging techniques of whole-brain atrophy measurement in multiple sclerosis.
    Zivadinov R; Grop A; Sharma J; Bratina A; Tjoa CW; Dwyer M; Zorzon M
    J Neuroimaging; 2005 Jan; 15(1):27-36. PubMed ID: 15574571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term brain atrophy changes in relapsing-remitting multiple sclerosis.
    Zivadinov R; Bagnato F; Nasuelli D; Bastianello S; Bratina A; Locatelli L; Watts K; Finamore L; Grop A; Dwyer M; Catalan M; Clemenzi A; Millefiorini E; Bakshi R; Zorzon M
    J Neurol Sci; 2004 Aug; 223(2):185-93. PubMed ID: 15337621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memory performance in multiple sclerosis patients correlates with central brain atrophy.
    Hildebrandt H; Hahn HK; Kraus JA; Schulte-Herbrüggen A; Schwarze B; Schwendemann G
    Mult Scler; 2006 Aug; 12(4):428-36. PubMed ID: 16900756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis.
    Brass SD; Benedict RH; Weinstock-Guttman B; Munschauer F; Bakshi R
    Mult Scler; 2006 Aug; 12(4):437-44. PubMed ID: 16900757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon beta-1a.
    Rudick RA; Fisher E; Lee JC; Duda JT; Simon J
    Mult Scler; 2000 Dec; 6(6):365-72. PubMed ID: 11212130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional gray matter atrophy in relapsing remitting multiple sclerosis: baseline analysis of multi-center data.
    Datta S; Staewen TD; Cofield SS; Cutter GR; Lublin FD; Wolinsky JS; Narayana PA; ;
    Mult Scler Relat Disord; 2015 Mar; 4(2):124-36. PubMed ID: 25787188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
    Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
    Sastre-Garriga J; Arévalo MJ; Renom M; Alonso J; González I; Galán I; Montalban X; Rovira A
    J Neurol Sci; 2009 Jul; 282(1-2):120-4. PubMed ID: 19157420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities.
    Traboulsee A; Dehmeshki J; Peters KR; Griffin CM; Brex PA; Silver N; Ciccarrelli O; Chard DT; Barker GJ; Thompson AJ; Miller DH
    Mult Scler; 2003 Dec; 9(6):566-73. PubMed ID: 14664468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis.
    Zivadinov R; De Masi R; Nasuelli D; Bragadin LM; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
    Neuroradiology; 2001 Apr; 43(4):272-8. PubMed ID: 11338408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrophy is detectable within a 3-month period in untreated patients with active relapsing remitting multiple sclerosis.
    Hardmeier M; Wagenpfeil S; Freitag P; Fisher E; Rudick RA; Kooijmans-Coutinho M; Clanet M; Radue EW; Kappos L;
    Arch Neurol; 2003 Dec; 60(12):1736-9. PubMed ID: 14676048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of T2 lesions in multiple sclerosis: A 13-year longitudinal study.
    Rudick RA; Lee JC; Simon J; Fisher E
    Ann Neurol; 2006 Aug; 60(2):236-42. PubMed ID: 16786526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain atrophy as a marker of cognitive impairment in mildly disabling relapsing-remitting multiple sclerosis.
    Sánchez MP; Nieto A; Barroso J; Martín V; Hernández MA
    Eur J Neurol; 2008 Oct; 15(10):1091-9. PubMed ID: 18727673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of individual cognitive profile on visuo-motor reorganization in relapsing-remitting multiple sclerosis.
    Gioia MC; Cerasa A; Liguori M; Passamonti L; Condino F; Vercillo L; Valentino P; Clodomiro A; Quattrone A; Fera F
    Brain Res; 2007 Sep; 1167():71-9. PubMed ID: 17689504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI phenotypes based on cerebral lesions and atrophy in patients with multiple sclerosis.
    Tauhid S; Neema M; Healy BC; Weiner HL; Bakshi R
    J Neurol Sci; 2014 Nov; 346(1-2):250-4. PubMed ID: 25220114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.